Repatha is the second in a new class of drugs called PCSK9 inhibitors to win FDA approval The drug is a second line of treatment for those who can't take or don't respond to widely used statins for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback